Legal Opinion
In Re OxyContin Antitrust Litigation
District Court, S.D. New York
Decided January 7, 2008No. 04 md. 1603(SHS). Nos. 06 Civ. 13095(SHS), 07 Civ. 03972(SHS), 07 Civ. 03973(SHS), 07 Civ. 04810(BHS)PublishedCited by 2 opinions
1Opinion of the Court
OPINION AND ORDER
SIDNEY H. STEIN, District Judge.
Plaintiffs Purdue Pharma, L.P!, the P.F. Laboratories, Inc., and Purdue Pharmaceuticals, L.P. (collectively, “Purdue”) bring this litigation pursuant to 35 U.S.C. § 271(e)(2) against defendant pharmaceutical companies Mallinckrodt, Inc., KV Pharmaceutical Co., and Actavis Totowa L.L.C. for allegedly infringing Purdue’s patents protecting a controlled-release oxycodone pain reliever sold under the brand name OxyContin. Due to the procedural posture of this litigation, the Court directed the parties to brief the issue of whether Purdue’s conduct…
2Cases cited16 opinions
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco CorporationCourt of Appeals for the Federal Circuit · 1995
- The Regents of the University of California v. Eli Lilly and CompanyCourt of Appeals for the Federal Circuit · 1997
- Paragon Podiatry Laboratory, Inc. v. Klm Laboratories, Inc.Court of Appeals for the Federal Circuit · 1993
- Critikon, Inc., Plaintiff-Cross v. Becton Dickinson Vascular Access, Inc.Court of Appeals for the Federal Circuit · 1997
11 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USADistrict Court, D. New Jersey · 2008
- Serby v. First Alert, Inc.District Court, E.D. New York · 2015